A new way to measure tumor response in kids: standardizing the neurologic exam

NCT ID NCT06981156

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study evaluates a neurologic exam scale called pNANO for children with brain or spinal cord tumors. The goal is to create a more objective and consistent way to assess tumor response. Children aged 1 and older with confirmed brain or spine tumors will be examined by multiple clinicians to measure how much the scores vary between observers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide a more objective and consistent way to measure how children with brain or spine tumors are responding to treatment.
What could go wrong
This is an observational study focused on measurement, not treatment. The scale may not prove more useful than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Family Children's Hospital

    RECRUITING

    Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.